WORLD-CHANGING BUSINESSES

MDR has a hands-on approach to delivering shareholder value that extends far beyond a staid Board of Directors position. We engage constructively on strategic, operational and financial issues, and often commit to short-term operating roles to navigate such challenges. 

MDR accelerates the transfer of technologies from research and early stage companies into thriving businesses. MDR believes that disruptive technologies are the cornerstone of improving healthcare at a reduced cost.

MDR has developed an extensive portfolio of self-generated IP derived from years of internal research and development. MDR utilizes these disruptive technologies to unlock value in portfolio companies underpinned by innovation and poised for growth. Our IP portfolio significantly improves research and development and dramatically shortens commercial lead times, resulting in higher equity returns and earlier exit opportunities.

MDR values long-term relationships with exceptional entrepreneurs and believe they serve as the foundation for future success. We have worked with many accomplished entrepreneurs whom we consider both colleagues and friends. MDR intends to expand such relations while forging new relations with prospective partners.

The MDR investment team consists of seasoned professionals with significant scientific and business acumen. Their diverse experiences include clinical and academic medicine, drug development, biochemistry, molecular biology, applied mathematics, engineering and finance. The varied perspectives of the investment team allow MDR to tactically identify opportunities, conduct intense fundamental due diligence for disciplined investment selection, and unlock value through active management.

ACTIVELY BUILDING